About the journal
About the Journal of Bioinformatics and Diabetes
Diabetes is studied at two scales at once: in sequence, expression and metabolite data held in public repositories, and at the bench and the bedside, where metabolism is measured in living systems.
The Journal of Bioinformatics and Diabetes exists so that careful work at either scale, and work that joins them, can be published, read and cited in the same place.
- ISSN 2374-9431
- Publisher Open Access Pub
- Access Open access
- Review Peer-reviewed
Two halves of one question
The journal's name sets its remit, and both halves of that name carry equal weight.
Bioinformatics supplies the methods that make large biological datasets tractable: sequence and structure analysis, expression and metabolite profiling, network and systems models, statistical and machine-learning approaches, and the databases and workflows that hold them. Diabetes supplies another set of biological and clinical questions; the two fields also meet when data-driven methods advance metabolic research.
Each half is read on its own terms. A computational contribution is read for whether its method is described well enough to be repeated and what its result establishes in its chosen biological setting. An experimental or clinical contribution is read for its design, its measurements, and the conditions under which they hold. Work that joins the two sits at the journal's center, and work that strengthens either side belongs here as well.
That breadth is deliberate. Diabetes research moves between scales — a variant, a transcript, a pathway, an islet, an organ, a person — and the journal is built to carry the whole of that range.
01
The data side
Genomes, transcriptomes, proteomes and metabolomes; the algorithms, statistical methods and models applied to them; and the databases, standards and workflows that let an analysis be run again.
02
The biological side
Insulin production and action, glucose metabolism and oxidative stress; type 1, type 2 and gestational diabetes; nutrition, pharmacology and experimental therapeutics; and the organs and tissues diabetes affects.
03
Where they meet
A dataset read against a mechanism, a model tested against a measurement, a question formed in one domain and examined in the other.
What the journal publishes
Peer-reviewed research, across the subjects the journal's title covers.
- Data and its methods
- Analysis of genomic, transcriptomic, proteomic and metabolomic data, with the algorithms, statistical methods and machine-learning approaches applied to it.
- Models of biological systems
- Pathway, network and systems models of metabolism and signaling, together with the assumptions they rest on and the evidence used to test them.
- Resources and reproducibility
- Databases, data standards, annotation and analysis workflows, described so that another group can run them.
- Mechanism and measurement
- Insulin production and action, glucose metabolism, oxidative stress, and the molecular processes through which diabetes develops.
- The forms diabetes takes
- Type 1, type 2 and gestational diabetes, and the complications that follow them across organs and tissues.
- Nutrition, pharmacology and therapeutics
- Nutrients, compounds and treatments examined experimentally or clinically, reported with the model, the doses and the conditions used.
- Diagnosis and clinical research
- Measurement, diagnosis and clinical investigation in diabetes and related metabolic disease.
Published work illustrates this remit; a manuscript is assessed against the scope above and the standards below.
Who it is written for
Readers and contributors are largely the same people, approaching one subject with different instruments.
The journal is written for researchers who read across the boundary: people whose main instrument is a sequencer, a mass spectrometer, an animal facility or a clinic, and who need to follow what the others have found.
What each of them is asked for is the same. A stated question. A method or model described well enough to be examined. Results reported with the conditions under which they were obtained, and conclusions that reach no further than those conditions allow.
- iComputational biologists, bioinformaticians and data scientists working on metabolic questions.
- iiGeneticists, molecular and cell biologists studying insulin, glucose handling and affected tissues.
- iiiNutrition, pharmacology and experimental therapeutics groups.
- ivClinical investigators and postgraduate researchers in diabetes and metabolic disease.
Editorial responsibility in practice
Peer review is how a claim is separated from an assertion before it enters the record. These are the terms it runs on.
Screening and review
All submissions undergo initial editorial screening. Manuscripts that meet the journal's scope and minimum requirements proceed to independent peer review.
Single-blind by default; double-blind review is available on request.
Assessment
Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts.
Editorial decisions are based on scope, scientific quality, methodological rigor, ethical compliance, reporting quality, and relevance to the journal.
Independence
Editorial decisions are independent of fees, membership, editorial or reviewer roles, and any paid service the publisher offers.
Editors recuse themselves from decisions on their own submissions; those manuscripts are handled independently.
The record
Accepted work is published open access, and the published record is kept complete: corrections and retractions stay in the archive alongside the articles they concern.
Full terms are set out in the editorial policies.
Where to read further
The pages that answer the questions this one raises.
- Aims and ScopeThe subject boundary in full, with the questions the journal invites.
- Editorial BoardThe editors who hold responsibility for what appears here.
- Instructions for AuthorsPreparation and submission requirements for a manuscript.
- ArchiveEvery issue the journal has published, in order.
Journal of Bioinformatics and Diabetes · ISSN 2374-9431 · Published by Open Access Pub.